Rapid Micro Biosystems annual r&d spending
2020
2021
2022
2023
2024
2025
Rapid Micro Biosystems R&D Spending Growth & History (RPID)
Rapid Micro Biosystems's r&d spending was $13.6M for fiscal 2025.
View full Rapid Micro Biosystems company overviewRapid Micro Biosystems annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.6M | −$994,000 | −6.81% |
| 2024 | 2024-12-31 | $14.6M | $1.8M | +13.86% |
| 2023 | 2023-12-31 | $12.8M | −$46,000 | −0.36% |
| 2022 | 2022-12-31 | $12.9M | $3.1M | +31.54% |
| 2021 | 2021-12-31 | $9.8M | $3.3M | +49.76% |
| 2020 | 2020-12-31 | $6.5M | — | — |
Rapid Micro Biosystems quarterly r&d spending
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.3M | $102,000 | +3.16% |
| Q1 2026 | 2026-03-31 | $3.4M | −$265,000 | −7.31% |
| Q4 2025 | 2025-12-31 | $3.2M | −$182,000 | −5.35% |
| Q3 2025 | 2025-09-30 | $3.5M | −$80,000 | −2.22% |
| Q2 2025 | 2025-06-30 | $3.2M | −$514,000 | −13.73% |
| Q1 2025 | 2025-03-31 | $3.6M | −$218,000 | −5.67% |
| Q4 2024 | 2024-12-31 | $3.4M | $84,000 | +2.53% |
| Q3 2024 | 2024-09-30 | $3.6M | $493,000 | +15.82% |
| Q2 2024 | 2024-06-30 | $3.7M | $511,000 | +15.81% |
| Q1 2024 | 2024-03-31 | $3.8M | $689,000 | +21.85% |
| Q4 2023 | 2023-12-31 | $3.3M | −$85,000 | −2.50% |
| Q3 2023 | 2023-09-30 | $3.1M | $143,000 | +4.81% |
| Q2 2023 | 2023-06-30 | $3.2M | $268,000 | +9.04% |
| Q1 2023 | 2023-03-31 | $3.2M | −$372,000 | −10.55% |
| Q4 2022 | 2022-12-31 | $3.4M | $547,000 | +19.15% |
| Q3 2022 | 2022-09-30 | $3.0M | $532,000 | +21.79% |
| Q2 2022 | 2022-06-30 | $3.0M | $628,000 | +26.87% |
| Q1 2022 | 2022-03-31 | $3.5M | $1.4M | +64.18% |
| Q4 2021 | 2021-12-31 | $2.9M | — | — |
| Q3 2021 | 2021-09-30 | $2.4M | $217,000 | +9.76% |
| Q2 2021 | 2021-06-30 | $2.3M | $1.1M | +87.86% |
| Q1 2021 | 2021-03-31 | $2.1M | — | — |
| Q3 2020 | 2020-09-30 | $2.2M | — | — |
| Q2 2020 | 2020-06-30 | $1.2M | — | — |
Rapid Micro Biosystems r&d spending trends
Over the last five fiscal years, Rapid Micro Biosystems's r&d spending increased from $6.5M to $13.6M, a change of $7.1M. The latest reported quarter, Q2 2026, shows $3.3M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rapid Micro Biosystems source filings ↗